BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 7522198)

  • 1. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
    Khoo SK; Jones IS
    Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
    Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of low-risk metastatic gestational trophoblastic tumors.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
    J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
    Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
    Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
    Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP
    Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.